Howe & Rusling’s West Pharmaceutical WST Stock Holding History

Howe & Rusling’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-440	Closed	-$19K	–	932
2014 Q1	$19K	Buy	+440	New	+$20.7K	﹤0.01%	467

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Howe & Rusling's WST Position: Q2 2014 in Review

Howe & Rusling sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 440 shares — an estimated $19K sold.

Howe & Rusling first reported a position in WST in Q1 2014 and held it in 1 quarter. The position peaked at $19K in Q1 2014. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

Howe & Rusling reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
Howe & Rusling sold 440 West Pharmaceutical shares in Q2 2014, an estimated $19K.
Howe & Rusling first reported a position in West Pharmaceutical in Q1 2014 and held it in 1 quarter.
Howe & Rusling's West Pharmaceutical position peaked at $19K in Q1 2014.
222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on Howe & Rusling's 13F filing for Q2 2014, filed 31 Jul 2014.